Evidence map›Paper›PMID 35198964›Full record

ArticleMatrix biology plus2022

Uncovering mediators of collagen degradation in the tumor microenvironment.

Marie-Louise Thorseth, Marco Carretta, Christina Jensen, Kasper Mølgaard, Henrik J Jürgensen, Lars H Engelholm, Niels Behrendt, Nicholas Willumsen, Daniel H Madsen

Abstract read
In one paragraph

Article in Matrix biology plus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Interactions between cancer-associated fibroblasts and the extracellular matrix in oesophageal cancer.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. A macrophage-collagen fragment axis mediates subcutaneous adipose tissue remodeling in mice.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Macrophages and the Extracellular Matrix.Results and problems in cell differentiation · 2024
    Review
  14. Article
  15. Review
  16. TheCancers · 2023
    Article
  17. Article
  18. Macrophages and Intervertebral Disc Degeneration.International journal of molecular sciences · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marie-Louise ThorsethNational Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev & Gentofte, Herlev, Denmark.
Marco CarrettaNational Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev & Gentofte, Herlev, Denmark.
Christina JensenBiomarkers and Research, Nordic Bioscience, Herlev, Denmark.
Kasper MølgaardNational Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev & Gentofte, Herlev, Denmark.
Henrik J JürgensenFinsen Laboratory, Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Lars H EngelholmFinsen Laboratory, Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Niels BehrendtFinsen Laboratory, Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Nicholas WillumsenBiomarkers and Research, Nordic Bioscience, Herlev, Denmark.
Daniel H MadsenNational Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev & Gentofte, Herlev, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased remodeling of the extracellular matrix in malignant tumors has been shown to correlate with tumor aggressiveness and a poor prognosis. This remodeling involves degradation of the original extracellular matrix (ECM) and deposition of a new tumor-supporting ECM. The main constituent of the ECM is collagen and collagen turnover mainly occurs in a sequential manner, where initial proteolytic cleavage of the insoluble fibers is followed by cellular internalization of large well-defined collagen fragments for lysosomal degradation. However, despite extensive research in the field, a lack of consensus on which cell types within the tumor microenvironment express the involved proteases still exists. Furthermore, the relative contribution of different cell types to collagen internalization is not well-established. Here, we developed quantitative

Indexed as

ATCC, American Type Culture CollectionCAF, cancer-associated fibroblastCancer-associated fibroblastsCollagen degradationCollagen endocytosisCPM, counts per minuteCRC, colorectal cancerECM, extracellular matrixELISA, enzyme-linked immunosorbent assayExtracellular matrix remodelingFAP, fibroblast activation protFMO, fluorescence minus oneFSP-1, fibroblast-specific protein 1IL, interleukinLC, lung cancerMatrix metalloproteinasesMMP, matrix metalloproteinaseMR, mannose receptorNK, natural killer cellOvC, ovarian cancerPDGFR, platelet-derived growth factor receptorTAM, tumor-associated macrophageTME, tumor microenvironmentTNF, tumor necrosis factorTumor-associated macrophagesTumor microenvironmentuPARAP, urokinase plasminogen activator receptor-associated proteinα-SMA, α-smooth muscle actin

Identifiers

PMID35198964
PMCPMC8841889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.